Provided by Tiger Trade Technology Pte. Ltd.

Avenue Therapeutics, Inc.

0.1916
0.0000
Volume:22.00
Turnover:3.85
Market Cap:393.50K
PE:-0.13
High:0.1916
Open:0.1916
Low:0.1916
Close:0.1916
52wk High:1.44
52wk Low:0.1653
Shares:2.05M
Float Shares:1.50M
Volume Ratio:0.00
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4649
EPS(LYR):-8.9962
ROE:-191.15%
ROA:-77.30%
PB:0.11
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
Avenue Therapeutics, Inc.
Exchange:
PINK
Establishment Date:
2015
Employees:
2
Office Location:
1111 Kane Concourse,Suite 301,Bay Harbor Islands,Florida,United States
Zip Code:
33154
Fax:
- -
Introduction:
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.